There is great concern in the industry that actions that involve the reduction or even removal of Source Data Verification will result in data quality issues that later are found to compromise the integrity of the study.
Read More
There is great concern in the industry that actions that involve the reduction or even removal of Source Data Verification will result in data quality issues that later are found to compromise the integrity of the study.
Doug Bain’s take on why EDC has not delivered on the original vision…
Over the next few months we will be offering up innovation topics for open discussion. First in the series relates to informed consent.
Kai Langel and Doug Bain provide commentary on PRO validation.
Electronic Data Capture and Clinical Data Management. Two classes of technology for helping to optimize clinical trials that have fans and foes. If we were to describe the two types…